Latest Trials Latest NewsFAQ

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Three Methods of Hemoglobin Monitoring

Completed

Conditions: Blood Loss

First Posted Date: 2008-11-18

Last Posted Date: 2013-03-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT00792597

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes

Completed

Conditions: Parkinson's Disease
Dystonia

Interventions: Procedure: interventional MRI for implantation of DBS electrodes
Device: DBS electrodes

First Posted Date: 2008-11-18

Last Posted Date: 2019-12-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 8

Registration Number: NCT00792532

Locations: 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States

Pharmacogenetics of Bupropion Metabolism

Completed

Conditions: Metabolism
Pharmacokinetics

First Posted Date: 2008-11-17

Last Posted Date: 2013-05-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 43

Registration Number: NCT00791869

Locations: 🇺🇸
San Francisco General Hospital-Clinical Research Ward, San Francisco, California, United States

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: vorinostat
Genetic: protein expression analysis
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis
Procedure: neoadjuvant therapy
Procedure: therapeutic conventional surgery

First Posted Date: 2008-11-10

Last Posted Date: 2017-08-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 17

Registration Number: NCT00788112

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Omega-3 Fatty Acids for Autism Treatment

Phase 2

Completed

Conditions: Autism

Interventions: Dietary Supplement: Omega-3 Fatty Acids

First Posted Date: 2008-11-06

Last Posted Date: 2012-08-31

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 27

Registration Number: NCT00786799

Locations: 🇺🇸
UC San Francisco, San Francisco, California, United States

Sleep Enhancement Training Study for Experienced Shiftworkers

Phase 1

Completed

Conditions: Shift-Work Sleep Disorder

Interventions: Behavioral: NIOSH shiftwork booklet
Behavioral: Sleep Enhancement Training System

First Posted Date: 2008-11-06

Last Posted Date: 2010-06-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 32

Registration Number: NCT00786357

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Sleep Enhancement Training Study for Novice Shiftworkers

Phase 1

Completed

Conditions: Shift-Work Sleep Disorder

Interventions: Behavioral: NIOSH shiftwork booklet
Behavioral: Sleep Enhancement Training System

First Posted Date: 2008-11-06

Last Posted Date: 2010-06-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT00786266

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Influence of MMP on Brain AVM Hemorrhage

Phase 1

Completed

Conditions: Arteriovenous Malformations
Cavernous Angiomas
Brain Aneurysms

Interventions: Drug: Doxycycline or Placebo

First Posted Date: 2008-10-31

Last Posted Date: 2013-08-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 33

Registration Number: NCT00783523

Locations: 🇺🇸
University of California, San Francisco, California, United States

Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells

Phase 1

Withdrawn

Conditions: Autoimmune Diseases

Interventions: Drug: Efalizumab

First Posted Date: 2008-10-22

Last Posted Date: 2013-05-14

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00777400

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: warfarin plus rifampin
Drug: warfarin

First Posted Date: 2008-10-22

Last Posted Date: 2013-07-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT00777855

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy